| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Breast Neoplasms | 35 | 2025 | 2760 | 2.160 |
Why?
|
| Breast | 13 | 2024 | 218 | 1.330 |
Why?
|
| Papilloma, Intraductal | 3 | 2013 | 5 | 0.800 |
Why?
|
| Carcinoma, Ductal, Breast | 6 | 2014 | 91 | 0.660 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 5 | 2014 | 73 | 0.570 |
Why?
|
| Carcinoma, Papillary | 4 | 2005 | 91 | 0.530 |
Why?
|
| Biopsy, Needle | 7 | 2011 | 238 | 0.520 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 3 | 2025 | 60 | 0.520 |
Why?
|
| Carcinoma, Lobular | 3 | 2014 | 26 | 0.510 |
Why?
|
| Epithelial Cells | 6 | 2024 | 941 | 0.480 |
Why?
|
| Precancerous Conditions | 4 | 2023 | 288 | 0.470 |
Why?
|
| Breast Diseases | 2 | 2011 | 38 | 0.420 |
Why?
|
| Lymph Nodes | 5 | 2017 | 397 | 0.380 |
Why?
|
| Mucocele | 1 | 2011 | 8 | 0.360 |
Why?
|
| Carcinoma in Situ | 2 | 2008 | 72 | 0.340 |
Why?
|
| Neoplasm Invasiveness | 6 | 2021 | 666 | 0.340 |
Why?
|
| STAT5 Transcription Factor | 2 | 2022 | 91 | 0.330 |
Why?
|
| Single-Cell Analysis | 3 | 2024 | 349 | 0.330 |
Why?
|
| Cell Transformation, Neoplastic | 5 | 2022 | 644 | 0.330 |
Why?
|
| Hyperplasia | 5 | 2023 | 203 | 0.330 |
Why?
|
| Cadherins | 2 | 2013 | 186 | 0.320 |
Why?
|
| Receptor, ErbB-2 | 6 | 2019 | 559 | 0.320 |
Why?
|
| Margins of Excision | 2 | 2025 | 59 | 0.290 |
Why?
|
| X-Linked Inhibitor of Apoptosis Protein | 1 | 2007 | 11 | 0.280 |
Why?
|
| Female | 41 | 2025 | 71587 | 0.270 |
Why?
|
| Head and Neck Neoplasms | 3 | 2007 | 698 | 0.270 |
Why?
|
| Mammography | 4 | 2018 | 132 | 0.260 |
Why?
|
| Uterine Cervical Dysplasia | 1 | 2006 | 32 | 0.250 |
Why?
|
| Biomarkers, Tumor | 4 | 2019 | 1718 | 0.240 |
Why?
|
| Mastectomy, Segmental | 1 | 2025 | 40 | 0.240 |
Why?
|
| Artifacts | 1 | 2005 | 110 | 0.230 |
Why?
|
| Cell Lineage | 3 | 2024 | 369 | 0.230 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2007 | 873 | 0.220 |
Why?
|
| Thyroid Neoplasms | 4 | 2017 | 255 | 0.220 |
Why?
|
| Aneuploidy | 1 | 2024 | 145 | 0.220 |
Why?
|
| Mass Spectrometry | 3 | 2024 | 371 | 0.210 |
Why?
|
| Neoplasm Metastasis | 5 | 2021 | 748 | 0.210 |
Why?
|
| Humans | 49 | 2025 | 133809 | 0.210 |
Why?
|
| Mammary Glands, Animal | 4 | 2022 | 477 | 0.210 |
Why?
|
| Stem Cells | 4 | 2018 | 752 | 0.200 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 2 | 2023 | 82 | 0.200 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2006 | 267 | 0.200 |
Why?
|
| Thiazoles | 1 | 2023 | 102 | 0.200 |
Why?
|
| Calcinosis | 3 | 2013 | 194 | 0.190 |
Why?
|
| Middle Aged | 16 | 2024 | 29350 | 0.190 |
Why?
|
| Diagnosis, Differential | 4 | 2018 | 1971 | 0.190 |
Why?
|
| Ultrasonography, Mammary | 4 | 2018 | 33 | 0.190 |
Why?
|
| RNA | 1 | 2025 | 601 | 0.180 |
Why?
|
| Metabolomics | 1 | 2025 | 456 | 0.180 |
Why?
|
| Cell Line, Tumor | 7 | 2021 | 3748 | 0.180 |
Why?
|
| Mammary Neoplasms, Animal | 2 | 2019 | 141 | 0.170 |
Why?
|
| Receptors, Estrogen | 3 | 2018 | 823 | 0.170 |
Why?
|
| Mice | 16 | 2023 | 18876 | 0.170 |
Why?
|
| Sentinel Lymph Node Biopsy | 2 | 2014 | 71 | 0.170 |
Why?
|
| Wnt Proteins | 1 | 2021 | 223 | 0.170 |
Why?
|
| Neoplasms | 3 | 2025 | 3023 | 0.170 |
Why?
|
| Adult | 14 | 2024 | 31928 | 0.160 |
Why?
|
| Lung Neoplasms | 3 | 2025 | 1792 | 0.160 |
Why?
|
| Uridine Diphosphate Glucose Dehydrogenase | 1 | 2019 | 5 | 0.160 |
Why?
|
| ErbB Receptors | 1 | 2021 | 304 | 0.160 |
Why?
|
| Gene Expression Profiling | 2 | 2024 | 1912 | 0.160 |
Why?
|
| DNA Copy Number Variations | 1 | 2024 | 1022 | 0.160 |
Why?
|
| Codon | 1 | 2019 | 108 | 0.150 |
Why?
|
| Cinnamates | 1 | 2018 | 15 | 0.150 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2019 | 137 | 0.150 |
Why?
|
| Granulomatous Mastitis | 1 | 2018 | 6 | 0.150 |
Why?
|
| Mammary Tumor Virus, Mouse | 1 | 2018 | 107 | 0.150 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2021 | 315 | 0.150 |
Why?
|
| Neoplasms, Hormone-Dependent | 1 | 2018 | 101 | 0.150 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2019 | 78 | 0.150 |
Why?
|
| Hyaluronic Acid | 1 | 2019 | 116 | 0.150 |
Why?
|
| Transcriptome | 1 | 2025 | 1126 | 0.150 |
Why?
|
| Molecular Imaging | 1 | 2018 | 65 | 0.140 |
Why?
|
| Animals | 18 | 2023 | 36364 | 0.140 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2009 | 3843 | 0.140 |
Why?
|
| Lymphocytes | 1 | 2019 | 440 | 0.140 |
Why?
|
| Indoles | 1 | 2018 | 201 | 0.140 |
Why?
|
| Phyllodes Tumor | 1 | 2017 | 11 | 0.140 |
Why?
|
| Tumor Suppressor Protein p53 | 3 | 2019 | 790 | 0.140 |
Why?
|
| Cell Differentiation | 5 | 2018 | 2026 | 0.140 |
Why?
|
| Neoadjuvant Therapy | 1 | 2019 | 404 | 0.140 |
Why?
|
| Aged, 80 and over | 7 | 2014 | 7194 | 0.140 |
Why?
|
| Aged | 9 | 2014 | 21701 | 0.130 |
Why?
|
| Janus Kinase 2 | 1 | 2018 | 131 | 0.130 |
Why?
|
| Organ Specificity | 1 | 2017 | 444 | 0.130 |
Why?
|
| Epithelial-Mesenchymal Transition | 2 | 2019 | 248 | 0.130 |
Why?
|
| Pregnancy-Associated Plasma Protein-A | 1 | 2016 | 8 | 0.130 |
Why?
|
| Nuclear Proteins | 1 | 2023 | 1334 | 0.130 |
Why?
|
| Biopsy, Large-Core Needle | 2 | 2013 | 34 | 0.130 |
Why?
|
| Transcription Factors | 4 | 2023 | 2703 | 0.130 |
Why?
|
| Multimodal Imaging | 1 | 2017 | 111 | 0.120 |
Why?
|
| Neoplasm, Residual | 2 | 2025 | 134 | 0.120 |
Why?
|
| Lymphatic Metastasis | 4 | 2014 | 453 | 0.120 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2018 | 820 | 0.120 |
Why?
|
| Carcinogenesis | 1 | 2019 | 364 | 0.120 |
Why?
|
| Signal Transduction | 5 | 2021 | 4893 | 0.120 |
Why?
|
| Extracellular Matrix | 2 | 2019 | 249 | 0.120 |
Why?
|
| Pancreatic Neoplasms | 1 | 2021 | 734 | 0.120 |
Why?
|
| Retrospective Studies | 6 | 2013 | 17457 | 0.120 |
Why?
|
| Lactation | 1 | 2016 | 201 | 0.110 |
Why?
|
| Thyroid Gland | 3 | 2021 | 115 | 0.110 |
Why?
|
| Disease Progression | 5 | 2021 | 2240 | 0.110 |
Why?
|
| Parathyroidectomy | 2 | 2021 | 50 | 0.110 |
Why?
|
| Molecular Targeted Therapy | 1 | 2017 | 407 | 0.110 |
Why?
|
| Pathology, Surgical | 1 | 2014 | 21 | 0.110 |
Why?
|
| Radiography | 2 | 2013 | 825 | 0.110 |
Why?
|
| Chemokine CCL1 | 1 | 2013 | 4 | 0.110 |
Why?
|
| Receptors, Fibroblast Growth Factor | 1 | 2013 | 60 | 0.100 |
Why?
|
| Fibroadenoma | 1 | 2013 | 10 | 0.100 |
Why?
|
| Mammary Glands, Human | 1 | 2013 | 83 | 0.100 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2013 | 149 | 0.100 |
Why?
|
| Immunohistochemistry | 5 | 2007 | 1764 | 0.100 |
Why?
|
| Follow-Up Studies | 5 | 2019 | 5503 | 0.100 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2019 | 1353 | 0.100 |
Why?
|
| Axilla | 2 | 2008 | 42 | 0.090 |
Why?
|
| eIF-2 Kinase | 1 | 2011 | 35 | 0.090 |
Why?
|
| Mice, Nude | 3 | 2021 | 775 | 0.090 |
Why?
|
| Pregnancy Complications | 1 | 2016 | 547 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2013 | 508 | 0.090 |
Why?
|
| Cell Movement | 4 | 2021 | 917 | 0.090 |
Why?
|
| Biopsy | 2 | 2018 | 1304 | 0.090 |
Why?
|
| Vascular Endothelial Growth Factor C | 1 | 2010 | 10 | 0.080 |
Why?
|
| Lymphangitis | 1 | 2010 | 5 | 0.080 |
Why?
|
| Tissue Array Analysis | 2 | 2021 | 143 | 0.080 |
Why?
|
| Chromatin | 2 | 2024 | 609 | 0.080 |
Why?
|
| Diagnostic Errors | 1 | 2014 | 344 | 0.080 |
Why?
|
| Cytodiagnosis | 1 | 2009 | 23 | 0.080 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2019 | 2935 | 0.080 |
Why?
|
| Neoplasm Transplantation | 2 | 2021 | 399 | 0.080 |
Why?
|
| Cells, Cultured | 3 | 2024 | 3165 | 0.080 |
Why?
|
| Antineoplastic Agents | 1 | 2019 | 1849 | 0.080 |
Why?
|
| Granular Cell Tumor | 1 | 2008 | 3 | 0.080 |
Why?
|
| Cell Proliferation | 4 | 2018 | 2539 | 0.070 |
Why?
|
| Sarcoidosis | 1 | 2008 | 62 | 0.070 |
Why?
|
| Trastuzumab | 2 | 2019 | 154 | 0.070 |
Why?
|
| Autophagy | 1 | 2011 | 420 | 0.070 |
Why?
|
| Keratins | 3 | 2019 | 52 | 0.070 |
Why?
|
| Carcinoma | 1 | 2010 | 322 | 0.070 |
Why?
|
| Pattern Recognition, Automated | 1 | 2007 | 49 | 0.070 |
Why?
|
| Prognosis | 4 | 2019 | 5068 | 0.060 |
Why?
|
| Conization | 1 | 2006 | 4 | 0.060 |
Why?
|
| Mice, Transgenic | 3 | 2019 | 2529 | 0.060 |
Why?
|
| Models, Anatomic | 1 | 2007 | 103 | 0.060 |
Why?
|
| Oxidative Stress | 1 | 2011 | 869 | 0.060 |
Why?
|
| Frozen Sections | 1 | 2025 | 31 | 0.060 |
Why?
|
| Endothelial Cells | 2 | 2023 | 543 | 0.060 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2007 | 234 | 0.060 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2019 | 1004 | 0.060 |
Why?
|
| Tamoxifen | 2 | 2018 | 376 | 0.060 |
Why?
|
| Thyroiditis, Autoimmune | 1 | 2004 | 9 | 0.060 |
Why?
|
| Clone Cells | 1 | 2024 | 180 | 0.060 |
Why?
|
| Mastectomy | 1 | 2024 | 81 | 0.050 |
Why?
|
| Antigens, CD | 1 | 2005 | 452 | 0.050 |
Why?
|
| Estrogen Receptor Modulators | 1 | 2023 | 39 | 0.050 |
Why?
|
| Neoplasm Grading | 2 | 2014 | 305 | 0.050 |
Why?
|
| Up-Regulation | 1 | 2005 | 905 | 0.050 |
Why?
|
| Artificial Intelligence | 1 | 2007 | 298 | 0.050 |
Why?
|
| Gene Expression | 1 | 2007 | 1614 | 0.050 |
Why?
|
| Immunity | 1 | 2023 | 188 | 0.050 |
Why?
|
| Cellular Reprogramming | 1 | 2023 | 135 | 0.050 |
Why?
|
| Models, Biological | 1 | 2007 | 1535 | 0.050 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2023 | 315 | 0.040 |
Why?
|
| Phosphorylation | 3 | 2013 | 1702 | 0.040 |
Why?
|
| Ubiquitin | 1 | 2021 | 148 | 0.040 |
Why?
|
| RNA Interference | 2 | 2013 | 542 | 0.040 |
Why?
|
| Wnt Signaling Pathway | 1 | 2021 | 205 | 0.040 |
Why?
|
| Neoplasm Staging | 2 | 2014 | 1388 | 0.040 |
Why?
|
| Uridine Diphosphate Glucuronic Acid | 1 | 2019 | 6 | 0.040 |
Why?
|
| In Vitro Techniques | 1 | 2021 | 991 | 0.040 |
Why?
|
| Chorioallantoic Membrane | 1 | 2019 | 12 | 0.040 |
Why?
|
| Membrane Proteins | 2 | 2005 | 1606 | 0.040 |
Why?
|
| Chick Embryo | 1 | 2019 | 131 | 0.040 |
Why?
|
| Risk Factors | 2 | 2018 | 11071 | 0.040 |
Why?
|
| Proteome | 1 | 2021 | 281 | 0.040 |
Why?
|
| PPAR gamma | 1 | 2019 | 86 | 0.040 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2024 | 961 | 0.040 |
Why?
|
| Leukocyte Common Antigens | 1 | 2019 | 93 | 0.040 |
Why?
|
| Pimozide | 1 | 2018 | 7 | 0.040 |
Why?
|
| Wnt1 Protein | 1 | 2018 | 73 | 0.040 |
Why?
|
| HEK293 Cells | 1 | 2021 | 812 | 0.040 |
Why?
|
| Cell Separation | 1 | 2019 | 234 | 0.040 |
Why?
|
| MCF-7 Cells | 1 | 2018 | 231 | 0.040 |
Why?
|
| Hyperprolactinemia | 1 | 2018 | 22 | 0.040 |
Why?
|
| Protein Array Analysis | 1 | 2018 | 107 | 0.040 |
Why?
|
| Heterografts | 1 | 2018 | 199 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2021 | 1135 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2019 | 395 | 0.040 |
Why?
|
| Age Factors | 1 | 2024 | 2978 | 0.040 |
Why?
|
| Risperidone | 1 | 2018 | 60 | 0.040 |
Why?
|
| Mice, SCID | 1 | 2019 | 612 | 0.030 |
Why?
|
| Glycerophospholipids | 1 | 2017 | 8 | 0.030 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2019 | 246 | 0.030 |
Why?
|
| Glycolipids | 1 | 2017 | 35 | 0.030 |
Why?
|
| Neoplastic Stem Cells | 2 | 2013 | 352 | 0.030 |
Why?
|
| Disease Models, Animal | 2 | 2019 | 4769 | 0.030 |
Why?
|
| Intraoperative Care | 1 | 2017 | 120 | 0.030 |
Why?
|
| Principal Component Analysis | 1 | 2017 | 160 | 0.030 |
Why?
|
| Sphingolipids | 1 | 2017 | 35 | 0.030 |
Why?
|
| Glucose Transporter Type 1 | 2 | 2006 | 26 | 0.030 |
Why?
|
| Estradiol | 1 | 2018 | 551 | 0.030 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2017 | 176 | 0.030 |
Why?
|
| Estrogens | 1 | 2018 | 522 | 0.030 |
Why?
|
| Quinazolines | 1 | 2017 | 184 | 0.030 |
Why?
|
| Phenotype | 1 | 2005 | 4530 | 0.030 |
Why?
|
| Young Adult | 1 | 2009 | 9902 | 0.030 |
Why?
|
| Genomics | 1 | 2023 | 1675 | 0.030 |
Why?
|
| Antipsychotic Agents | 1 | 2018 | 388 | 0.030 |
Why?
|
| Fatty Acids | 1 | 2017 | 370 | 0.030 |
Why?
|
| Receptors, Progesterone | 1 | 2018 | 896 | 0.030 |
Why?
|
| Macrophages | 1 | 2019 | 701 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2017 | 623 | 0.030 |
Why?
|
| False Negative Reactions | 1 | 2014 | 90 | 0.030 |
Why?
|
| Mutation | 2 | 2019 | 6292 | 0.030 |
Why?
|
| Diphenylamine | 1 | 2013 | 5 | 0.030 |
Why?
|
| Receptors, CCR8 | 1 | 2013 | 1 | 0.030 |
Why?
|
| Snail Family Transcription Factors | 1 | 2013 | 27 | 0.030 |
Why?
|
| Endothelium, Lymphatic | 1 | 2013 | 10 | 0.030 |
Why?
|
| Chemotactic Factors | 1 | 2013 | 21 | 0.030 |
Why?
|
| Phosphoproteins | 2 | 2006 | 454 | 0.030 |
Why?
|
| Time-Lapse Imaging | 1 | 2013 | 8 | 0.030 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2013 | 45 | 0.030 |
Why?
|
| Aldehyde Dehydrogenase | 1 | 2013 | 45 | 0.030 |
Why?
|
| Spheroids, Cellular | 1 | 2013 | 63 | 0.030 |
Why?
|
| Lymphatic Vessels | 1 | 2013 | 37 | 0.030 |
Why?
|
| Chemotaxis | 1 | 2013 | 63 | 0.030 |
Why?
|
| Cyclin D1 | 1 | 2013 | 123 | 0.030 |
Why?
|
| Microscopy, Fluorescence, Multiphoton | 1 | 2013 | 42 | 0.030 |
Why?
|
| Side-Population Cells | 1 | 2013 | 12 | 0.030 |
Why?
|
| CD24 Antigen | 1 | 2013 | 32 | 0.030 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2006 | 510 | 0.030 |
Why?
|
| Palliative Care | 1 | 2017 | 460 | 0.030 |
Why?
|
| Benzamides | 1 | 2013 | 125 | 0.030 |
Why?
|
| Hyaluronan Receptors | 1 | 2013 | 68 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2019 | 1834 | 0.020 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2017 | 553 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2013 | 275 | 0.020 |
Why?
|
| Histones | 2 | 2006 | 569 | 0.020 |
Why?
|
| Gene Amplification | 1 | 2013 | 247 | 0.020 |
Why?
|
| Trans-Activators | 2 | 2006 | 830 | 0.020 |
Why?
|
| Inflammation Mediators | 1 | 2013 | 262 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2013 | 1102 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2013 | 713 | 0.020 |
Why?
|
| Adolescent | 1 | 2009 | 20542 | 0.020 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2013 | 271 | 0.020 |
Why?
|
| Apoptosis | 1 | 2018 | 1931 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2011 | 317 | 0.020 |
Why?
|
| Inflammation | 1 | 2019 | 1595 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2011 | 363 | 0.020 |
Why?
|
| Adenosine Triphosphate | 1 | 2011 | 295 | 0.020 |
Why?
|
| Lymphangiogenesis | 1 | 2010 | 18 | 0.020 |
Why?
|
| Pyrimidines | 1 | 2013 | 417 | 0.020 |
Why?
|
| Referral and Consultation | 1 | 2014 | 570 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2011 | 400 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2011 | 643 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2011 | 338 | 0.020 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2011 | 256 | 0.020 |
Why?
|
| Estrogen Receptor alpha | 1 | 2013 | 473 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 2011 | 464 | 0.020 |
Why?
|
| Cell Survival | 1 | 2011 | 890 | 0.020 |
Why?
|
| Male | 3 | 2018 | 65830 | 0.020 |
Why?
|
| Parathyroid Glands | 1 | 2007 | 30 | 0.020 |
Why?
|
| DNA-Binding Proteins | 2 | 2006 | 2161 | 0.020 |
Why?
|
| Cytokines | 1 | 2013 | 1396 | 0.020 |
Why?
|
| Transplantation, Autologous | 1 | 2007 | 285 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2011 | 921 | 0.020 |
Why?
|
| False Positive Reactions | 1 | 2006 | 145 | 0.020 |
Why?
|
| Cell Line | 1 | 2011 | 2837 | 0.020 |
Why?
|
| Melanoma | 1 | 2013 | 974 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2013 | 2123 | 0.010 |
Why?
|
| Hypoxia | 1 | 2006 | 262 | 0.010 |
Why?
|
| Reoperation | 1 | 2007 | 867 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2007 | 702 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2006 | 627 | 0.010 |
Why?
|
| Pregnancy | 1 | 2016 | 7513 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2011 | 3968 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2008 | 12994 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2007 | 2157 | 0.010 |
Why?
|
| Kidney Failure, Chronic | 1 | 2007 | 911 | 0.010 |
Why?
|